PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig’s Disease
TORONTO, May 25, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage...
News
Motus GI’s Pure-Vu System® Adopted by Sinai Hospital of Baltimore
Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of GI endoscopy proceduresFORT LAUDERDALE, Fla., May 25, 2021...
TRACON Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
Avid Bioservices to Serve as Commercial Manufacturer for ADC Therapeutics’ ZYNLONTA™ (Loncastuximab Tesirine-Lpyl)
ZYNLONTA™ Recently Approved as First and Only CD19-Targeted Antibody Drug Conjugate for Single-Agent Treatment for Adult Patients with Relapsed or...
Immutep To Present At The Jefferies Virtual Healthcare Conference
SYDNEY, AUSTRALIA, May 25, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology...
Shape Therapeutics to Present the Discovery of Muscle-Specific AAVs at the Jefferies 2021 Virtual Healthcare Conference
SEATTLE, May 25, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene...
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
MINNEAPOLIS, May 25, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Connect Biopharma Announces First Subject Dosed in Phase I Trial Evaluating Safety, Tolerability and Pharmacokinetic Profile of CBP-174 in Healthy Adult Subjects
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus SAN DIEGO and TAICANG, SUZHOU, China,...
Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases
LEXINGTON, Mass. and CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Alloy Therapeutics (“Alloy”) and Pyxis Oncology ("Pyxis") today announced...
Enosi Life Sciences Featured on America’s Next Investment
Company’s appearance comes concurrently with its Regulation D, 506c OfferingEUGENE, Ore., May 25, 2021 (GLOBE NEWSWIRE) -- Enosi Life Sciences...
European Commission approves Venclyxto-based combinations for adults with newly diagnosed acute myeloid leukaemia who are ineligible for intensive chemotherapy
With hypomethylating agents significantly improved complete response rates in certain adults with newly diagnosed acute myeloid leukaemiaIn the VIALE-A study,...
Kronos Bio to Highlight Progress Across Pipeline and Outline Growth Strategy at Virtual R&D Day Today
Unveils development strategy for lanraplenib (LANRA), which will expand addressable patient population for SYK inhibitor portfolio in acute myeloid leukemia...
Avadel Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
DUBLIN, Ireland, May 25, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an...
NeuBase Therapeutics Appoints Dr. Kia Motesharei Chief Business and Strategy Officer
Expansion of management team continues with addition of an industry leader with deep experience in business development, licensing, and strategy...
Selecta Biosciences to Participate at the Jefferies Virtual Healthcare Conference
WATERTOWN, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
Universe Pharmaceuticals INC Enters into Letter of Intent for Strategic Cooperation with Kitanihon Pharmaceutical Co., Ltd.
Ji’an, Jiangxi, China, May 25, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and...
JenaValve Technology Receives CE Mark for its Trilogy™ TAVI System for the Treatment of Aortic Regurgitation and Aortic Stenosis
IRVINE, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer, and manufacturer of differentiated transcatheter aortic valve implantation...
Asylia Therapeutics, Inc. Announces Closing of $14.5 Million Series A Financing
Proceeds will support development of novel antibody drugs that convert immunologically “cold” tumors into treatable “hot” tumors, with the goal...
Novan Announces 1-for-10 Reverse Stock Split
DURHAM, N.C., May 25, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it...
Promaxo Taps Dr. Srirama Venkataraman as VP of Clinical Research & Strategy
With previous roles at Philips and Stryker, Dr. Venkataraman will bring his expertise to Promaxo’s MRI and robotic platform OAKLAND,...